High-risk groups of patients with Stage II colon carcinoma.

S Merkel; A Wein; K Günther; Thomas  Papadopoulos; W Hohenberger; P Hermanek

High-risk groups of patients with Stage II colon carcinoma.

S Merkel, A Wein, K Günther, Thomas Papadopoulos (Co-author), W Hohenberger, P Hermanek

Research output: Contribution to journal › Original Article › peer-review

109 Citations (Web of Science)

Original language	English
Pages (from-to)	1435-1443
Journal	CANCER
Volume	92
Issue number	6
Publication status	Published - 2001

Keywords

ACTIVE SPECIFIC IMMUNOTHERAPY
COLORECTAL-CANCER
ADJUVANT CHEMOTHERAPY
ALLELIC LOSS
PROGNOSTIC FACTORS
CHROMOSOME 18Q
DUKES-B
SURVIVAL
ONCOLOGY
MARKERS

Cite this

@article{f1d44be362524a02baed677854c03f7a,

title = "High-risk groups of patients with Stage II colon carcinoma.",

keywords = "ACTIVE SPECIFIC IMMUNOTHERAPY, COLORECTAL-CANCER, ADJUVANT CHEMOTHERAPY, ALLELIC LOSS, PROGNOSTIC FACTORS, CHROMOSOME 18Q, DUKES-B, SURVIVAL, ONCOLOGY, MARKERS",

author = "S Merkel and A Wein and K G{\"u}nther and Thomas Papadopoulos and W Hohenberger and P Hermanek",

year = "2001",

language = "English",

volume = "92",

pages = "1435--1443",

journal = "CANCER",

issn = "0008-543X",

publisher = "Wiley Verlag ",

number = "6",

}

TY - JOUR

T1 - High-risk groups of patients with Stage II colon carcinoma.

AU - Merkel, S

AU - Wein, A

AU - Günther, K

AU - Papadopoulos, Thomas

AU - Hohenberger, W

AU - Hermanek, P

PY - 2001

Y1 - 2001

KW - ACTIVE SPECIFIC IMMUNOTHERAPY

KW - COLORECTAL-CANCER

KW - ADJUVANT CHEMOTHERAPY

KW - ALLELIC LOSS

KW - PROGNOSTIC FACTORS

KW - CHROMOSOME 18Q

KW - DUKES-B

KW - SURVIVAL

KW - ONCOLOGY

KW - MARKERS

M3 - Original Article

C2 - 11745220

SN - 0008-543X

VL - 92

SP - 1435

EP - 1443

JO - CANCER

JF - CANCER

IS - 6

ER -